The clinical treatment strategy for Bismuth-Corlette type Ⅲ hilar cholangiocarcinoma
10.3760/cma.j.issn.1007-631X.2019.01.004
- VernacularTitle:Bismuth-CorletteⅢ型肝门部胆管癌治疗策略
- Author:
Wei DAI
1
;
Yeben QIAN
Author Information
1. 安徽医科大学第一附属医院肝胆胰外科
- Keywords:
Bile duct neoplasms;
Hepatectomy;
Anastomosis,surgical;
Liver failure,acute
- From:
Chinese Journal of General Surgery
2019;34(1):14-17
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the result of peri-hilar resection(extrahepatic bile duct resection plus local hepatectomy) and hepaticojejunostomy for the treatment of Bismuth-Corlette type Ⅲ hilar cholangiocarcinoma (HCCA).Methods This study was conducted on 37 patients divided into group A undergoing peri-hilar resection (extrahepatic bile duct resection combined with local hepatectomy) and hepaticojejunostomy (n =17) and group B treated by extrahepatic bile duct combined with hemihepatectomy and hemicaudatectomy and cholangioenterostomy (n =20).Results The incidence of postoperative acute liver failure was lower in group A than in group B (x2 =5,332,P =0.021).There was no significant difference in clinical data and survival rate (OS) between the two groups of patients and other complications.Conclusion For patients with Bismuth-Corlette type Ⅲ HCCA,the peri-hilar resection (extrahepatic bile duct combined with local hepatectomy)and hepaticojejunostomy reduces the incidence of postoperative acute liver failure.
